EUVIMEDEUVIMED entdecken
Crossref

GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes

Rebecca J Noort iD, Wesam Salman, Camila Fuchs, Ursula Braun, David Pace, Kathleen A Hodgkinson iD, Jessica L Esseltine iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.01025.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Rebecca J Noort und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Cardiac, Myocardial Contraction, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Stem Cell Network (SCN), Canadian Government | Canadian Institutes of Health Research (CIHR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is the first characterization of induced pluripotent stem cell-cardiomyocytes (iPSC-CMs) from Newfoundland patients with ACM. We find that ACM iPSC-CMs exhibit extreme proarrhythmic tendencies that can be normalized with GSK3 inhibition. Importantly, GSK3 inhibition is accompanied by a significant increase in key proteins, such as β-catenin and Lamin A/C, pointing toward a possible mechanism both for disease pathogenesis and therapy via GSK3 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsMyocytes, CardiacMyocardial ContractionCardiomyopathiesGlycogen Synthase Kinase 3Arrhythmias, CardiacProtein Kinase InhibitorsHumansMaleMembrane ProteinsNewfoundland and Labrador

Stichwörter der Autor:innen

CRISPR-Cas9 gene editingarrhythmogenic cardiomyopathycardiomyocyteshuman-induced pluripotent stem cellstransmembrane protein 43

Substanzen

TMEM43 protein, humanMembrane ProteinsGlycogen Synthase Kinase 3Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
  • Discipline of Surgery, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
  • Division of Population Health and Applied Health Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.

ORCID-Profile: Rebecca J Noort, Kathleen A Hodgkinson, Jessica L Esseltine

Förderung

  • Stem Cell Network (SCN)
  • Canadian Government | Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Noort, R. J., Salman, W., Fuchs, C., Braun, U., Pace, D., Hodgkinson, K. A., & Esseltine, J. L. (2025). GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.01025.2024

Vancouver

Noort RJ, Salman W, Fuchs C, Braun U, Pace D, Hodgkinson KA, et al. GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.01025.2024

BibTeX
@article{Noort2025,
  author = {Noort, Rebecca J and Salman, Wesam and Fuchs, Camila and Braun, Ursula and Pace, David and Hodgkinson, Kathleen A and Esseltine, Jessica L},
  title = {GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.01025.2024}
}
Kostenlos starten →